RETRACTED ARTICLE: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

Favipiravir is considered a potential treatment for COVID-19 due its efficacy against different viral infections. We aimed to explore the safety and efficacy of favipiravir in treatment of COVID-19 mild and moderate cases. It was randomized-controlled open-label interventional phase 3 clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Dabbous, Hany M., El-Sayed, Manal H., El Assal, Gihan, Elghazaly, Hesham, Ebeid, Fatma F. S., Sherief, Ahmed F., Elgaafary, Maha, Fawzy, Ehab, Hassany, Sahar M., Riad, Ahmed R., TagelDin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012649/
https://www.ncbi.nlm.nih.gov/pubmed/33790308
http://dx.doi.org/10.1038/s41598-021-85227-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012649/
https://www.ncbi.nlm.nih.gov/pubmed/33790308
http://dx.doi.org/10.1038/s41598-021-85227-0

Ejemplares similares